COURTNEY GREGORY: Open Payments
NPI 1861190126 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 7 payments from 4 companies in 2025. Trend: 2023 $625 · 2024 $202 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 4 | $180 |
| BridgeBio Pharma, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
Products named: AMVUTTRA, Attruby, LEQVIO, Kerendia.
Industry payments across GA — which companies pay providers there.
